NASDAQ: $VTRS
Viatris Inc. has officially announced the schedule for reporting its financial outcomes for the fourth quarter and the entirety of the 2025 fiscal year. This important update for investors and stakeholders is set for release on Thursday, February 26, 2026.
Following the release of the comprehensive financial figures, Viatris will host a conference call and webcast to discuss the results and provide further context on the company’s performance and strategic direction. The details regarding the exact time for this conference call are expected to be provided closer to the reporting date.
Upcoming Investor Event
In addition to the quarterly earnings announcement, Viatris has also scheduled a dedicated Investor Event. This event will take place on Wednesday, March 19, 2026. These gatherings are key opportunities for the management team to elaborate on operational achievements, outline future plans, and engage with the financial community.
The company encourages interested parties, including investors, analysts, and the media, to monitor the Investor Relations section of the Viatris website for further specifics concerning the webcasts, dial-in numbers, and presentation materials related to both the earnings call and the March investor event.
Viatris remains committed to transparency and timely communication regarding its financial health and progress towards its long-term objectives. The scheduling of these events provides essential touchpoints for understanding the trajectory of the global healthcare company.
About Viatris
Viatris Inc. is a global healthcare company delivering a broad range of treatments that span complex biologics and trusted branded and generic products for patients worldwide. The company’s mission is to empower people worldwide to live healthier at every stage of life.